isibhengezo_sekhasi

Izindaba

Isaziso Esibalulekile-I-Suzhou Myland Izoletha imikhiqizo emisha embukisweni we-CPHI & PMEC China 2024

Izindaba ezinhle!

I-Suzhou Myland Pharm & Nutrition Inc. izobamba iqhaza ku-CPHI & PMEC China 2024 ezoba se-Shanghai New International Expo Center kusukela ngoJuni 19 kuya zingama-21, 2024. Kulo mbukiso, iSuzhou Myland Pharm & Nutrition Inc. izokhombisa ngemikhiqizo yayo yakamuva emisha nezisombululo, futhi ibonise amakhono ayo akamuva emkhakheni we-biotechnology kubaholi nozakwethu bezimboni. Sithemba ukuqhubeka nokuqinisa amandla ethu ezimakethe kanye nokusebenzisana kwezimboni ngalo mbukiso.

I-CPHI kanye ne-PMEC I-China iwuphawu lwemboni olukhethekile, ukwenziwa kwamazwe ngamazwe, kanye nezinga eliphezulu njengokuncintisana kwayo okuyinhloko. Ibone izinguquko eziphawulekayo embonini yezemithi yaseShayina isuka "ekuthengisweni okukhulu kwamanye amazwe kanye nokuthunyelwa kwamanye amazwe okukhulu" kuya "kumpahla ephuma ngaphandle kwekhwalithi kanye nokuthunyelwa kwempahla okuhle kakhulu" eminyakeni embalwa edlule. Njengamanje, izinkampani eziningi ezingamavulandlela sezijoyine i-CPHI kanye ne-PMEC yaseShayina, zadweba ezazo izinhlelo zokusebenza phakathi neminyaka yokusebenzisana kwezimboni, futhi kancane kancane zakha i-latitude nobude bephethini yezimboni, zazuza ukuncintisana okuqinile kwezimakethe zamazwe ngamazwe. Njengomunye wabakhangisi, iSuzhou Myland izokhombisa ngokugcwele ubuchwepheshe namandla ayo emkhakheni we-biomedicine.

mylandsupplement

Njengenkampani eneminyaka engaphezu kwengu-30 yokuhlangenwe nakho kwe-R&D kanye nokukhiqizwa kwemikhiqizo yokudla okunempilo, i-Suzhou Myland Pharm & Nutrition Inc. okwamanje igxile ku-R&D kanye nokukhiqizwa ngezinga elikhulu kwezithako zezempilo ezihlanganiswe ngamakhemikhali. Izigaba zayo zebhizinisi zihlanganisa:
1. Izithako zokudla: I-Calcium L-threonate, i-Magnesium L-threonate, i-Magnesium Taurate
2. Izinto zokusetshenziswa zomkhiqizo wezempilo: izithasiselo zokudla ze-nootropic nezilwa nokuguga, njenge-Urolithin A, i-Deazaflavin, i-ketone esters, ne-spermidine
3. Ama-intermediate athuthukile: i-antidepressant, i-anticancer, nochungechunge lwe-antitumor, njenge-citicoline sodium, i-Galantamine Hydrobromide.
4. Ukuhlanganiswa/ukucubungula okwenziwe ngokwezifiso: Yamukela izivivinyo zokuhlola kanye nokukhiqizwa kwezentengiso okuphathiswe amakhasimende omhlaba.
Imikhiqizo eyinhloko ihlanganisa: i-ketone esters, i-urolithin A, i-urolithin B, i-spermidine, i-salidroside, i-spermidine trihydrochloride, i-spermidine tetrahydrochloride, i-niacin yethusi, njll. Imikhiqizo ehlukene inemiphumela ehlukene. Imiphumela eyinhloko yomkhiqizo ihlanganisa ukulwa nokuguga, ukunikeza amandla emzimbeni, ukwehlisa i-lipids yegazi, ukuzinzisa umfutho wegazi, ukuthuthukisa isifo senhliziyo nemithambo yegazi, njll. Phakathi kwazo, umkhiqizo wethu okhethekile i-urolithin A uthandwa kakhulu emakethe.

Njengombukiso, ithimba lenkampani lenze amalungiselelo aphelele. Ngeke nje inikeze izivakashi ulwazi oluningiliziwe lomkhiqizo kanye nemibuzo yokubonisana nobuchwepheshe embukisweni, kodwa futhi izoqhuba ukuxhumana okujulile nezivakashi ezivela ezimbonini ezihlobene ukuze kuzuzwe ukwabelana ngolwazi, ukushintshana kwezobuchwepheshe, nokwanda kwezimakethe. Futhi bheka amanye amathuba okubambisana. Mayelana nalo mbukiso, umuntu ophethe le nkampani uthe: "Sihlonipheke kakhulu ngokubamba iqhaza ku-CPHI & PMEC China 2024. Leli yithuba elihle kakhulu lokuhlanganyela impumelelo yethu yakamuva kanye nokuqanjwa okusha kwezobuchwepheshe nozakwethu bemboni. Sibheke ngabomvu ukuxhumana no amakhasimende ethu kanye nozakwethu ngombukiso Yakha ubudlelwano obuseduze nochwepheshe bemboni ukuze ngokubambisana baqhubekisele phambili imboni.”

Imininingwane Yombukiso :

Igama Lombukiso :I-CPHI & PMEC China 2024

Isikhathi : 2024.6.19-6.21

Indawo : I-Shanghai New International Expo Centre

Ihholo Lombukiso Lenkampani No. : E4C06

Sikumema ngobuqotho ukuthi uvakashele idokodo le-Suzhou Myland Pharm & Nutrition Inc. ukuze uxoxe ngokubambisana futhi ufune intuthuko efanayo. Ngibheke ngabomvu ukukubona!


Isikhathi sokuthumela: Feb-04-2024